{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:40:40Z","timestamp":1753890040646,"version":"3.41.2"},"reference-count":25,"publisher":"Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,28]]},"DOI":"10.31744\/einstein_journal\/2025gs0390","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T13:02:36Z","timestamp":1743426156000},"source":"Crossref","is-referenced-by-count":0,"title":["Hepatorenal Syndrome: direct treatment costs and characteristics of patients admitted to intensive care"],"prefix":"10.31744","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7151-6042","authenticated-orcid":false,"given":"Franciele Robes","family":"Hortel\u00e3","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6635-7892","authenticated-orcid":false,"given":"Rodrigo Sfredo","family":"Kruger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3891-867X","authenticated-orcid":false,"given":"Val\u00e9ria Filomena de","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1765-7570","authenticated-orcid":false,"suffix":"Junior","given":"Hipolito","family":"Carraro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5624-2891","authenticated-orcid":false,"given":"Dominique Ara\u00fajo","family":"Muzzillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9210-8817","authenticated-orcid":false,"given":"S\u00e9rgio Candido","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16942","reference":[{"key":"key20250331124123_B1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000318993","article-title":"Novel Definition of Hepatorenal Syndrome: clinical Consequences","volume":"28","author":"Fernandez","year":"2011","unstructured":"1. Fernandez J, Arroyo V. Novel Definition of Hepatorenal Syndrome: clinical Consequences. Front Gastrointest Res. 2011;28:122-9.","journal-title":"Front Gastrointest Res"},{"issue":"6","key":"key20250331124123_B2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4254\/wjh.v9.i6.293","article-title":"Hepatorenal syndrome: update on diagnosis and therapy","volume":"9","author":"Acevedo","year":"2017","unstructured":"2. Acevedo JG, Cramp ME. Hepatorenal syndrome: update on diagnosis and therapy. World J Hepatol. 2017;9(6):293-9.","journal-title":"World J Hepatol"},{"issue":"3","key":"key20250331124123_B3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis","volume":"53","author":"European Association for the Study of the Liver","year":"2010","unstructured":"3. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53(3):397-417.","journal-title":"J Hepatol"},{"issue":"1","key":"key20250331124123_B4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-2008-1040323","article-title":"Pathogenesis and treatment of hepatorenal syndrome","volume":"28","author":"Arroyo","year":"2008","unstructured":"4. Arroyo V, Fernandez J, Gin\u00e8s P. Pathogenesis and treatment of hepatorenal syndrome. Semin Liver Dis. 2008;28(1):81-95.","journal-title":"Semin Liver Dis"},{"issue":"1","key":"key20250331124123_B5","doi-asserted-by":"crossref","DOI":"10.1186\/cc11188","article-title":"Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"16","author":"Nadim","year":"2012","unstructured":"5. Nadim MK, Kellum JA, Davenport A, Wong F, Davis C, Pannu N, Tolwani A, Bellomo R, Genyk YS; ADQI Workgroup. Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2012;16(1):R23. Review.","journal-title":"Crit Care"},{"issue":"3","key":"key20250331124123_B6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MEG.0000000000000537","article-title":"Terlipressin versus noradrenaline in the treatment of hepatorenal syndrome: systematic review with meta-analysis and full economic evaluation","volume":"28","author":"Mattos","year":"2016","unstructured":"6. Mattos \u00c2Z, Mattos AA, Ribeiro RA. Terlipressin versus noradrenaline in the treatment of hepatorenal syndrome: systematic review with meta-analysis and full economic evaluation. Eur J Gastroenterol Hepatol. 2016;28(3):345-51.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"1","key":"key20250331124123_B7","first-page":"17","article-title":"Epidemiology, Pathophysiology, and Management of Hepatorenal Syndrome","volume":"39","author":"Amin","year":"2019","unstructured":"7. Amin AA, Alabsawy EI, Jalan R, Davenport A. Epidemiology, Pathophysiology, and Management of Hepatorenal Syndrome. SeminNephrol. 2019;39(1):17-30.","journal-title":"SeminNephrol"},{"issue":"2","key":"key20250331124123_B8","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/j.gastro.2010.07.043","article-title":"Prognostic importance of the cause of renal failure in patients with cirrhosis","volume":"140","author":"Mart\u00edn-Llah\u00ed","year":"2011","unstructured":"8. Mart\u00edn-Llah\u00ed M, Guevara M, Torre A, Fagundes C, Restuccia T, Gilabert R, et al. Prognostic importance of the cause of renal failure in patients with cirrhosis. Gastroenterology. 2011;140(2):488-96.e4.","journal-title":"Gastroenterology"},{"issue":"1","key":"key20250331124123_B9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/jim-d-15-00181","article-title":"Hepatorenal syndrome in hospitalized patients with chronic liver disease: results from the Nationwide Inpatient Sample 2002-2012","volume":"64","author":"Pant","year":"2016","unstructured":"9. Pant C, Jani BS, Desai M, Deshpande A, Pandya P, Taylor R, et al. Hepatorenal syndrome in hospitalized patients with chronic liver disease: results from the Nationwide Inpatient Sample 2002-2012. J Investig Med. 2016;64(1):33-8.","journal-title":"J Investig Med"},{"issue":"7245","key":"key20250331124123_B10","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1136\/bmj.320.7245.1335","article-title":"Economic note: cost of illness studies","volume":"320","author":"Byford","year":"2000","unstructured":"10. Byford S, Torgerson DJ, Raftery J. Economic note: cost of illness studies. BMJ. 2000;320(7245):1335.","journal-title":"BMJ"},{"issue":"5","key":"key20250331124123_B11","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1590\/1415-52732014000500007","article-title":"Bases metodol\u00f3gicas para estudos de custos da doen\u00e7a no Brasil","volume":"27","author":"Oliveira","year":"2014","unstructured":"11. Oliveira ML, Santos LM, Silva EN. Bases metodol\u00f3gicas para estudos de custos da doen\u00e7a no Brasil. Rev Nutr. 2014;27(5):585-95.","journal-title":"Rev Nutr"},{"issue":"5","key":"key20250331124123_B12","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/13696998.2019.1580201","article-title":"The burden of illness of hepatorenal syndrome (HRS) in the United States: a retrospective analysis of electronic health records","volume":"22","author":"Jamil","year":"2019","unstructured":"12. Jamil K, Huang X, Lovelace B, Pham AT, Lodaya K, Wan G. The burden of illness of hepatorenal syndrome (HRS) in the United States: a retrospective analysis of electronic health records. J Med Econ. 2019;22(5):421-9.","journal-title":"J Med Econ"},{"issue":"6","key":"key20250331124123_B13","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jhep.2012.01.012","article-title":"Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study","volume":"56","author":"Singh","year":"2012","unstructured":"13. Singh V, Ghosh S, Singh B, Kumar P, Sharma N, Bhalla A, et al. Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study. J Hepatol 2012. 2012;56(6):1293-8.","journal-title":"J Hepatol"},{"issue":"9","key":"key20250331124123_B14","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis","volume":"56","author":"Salerno","year":"2007","unstructured":"14. Salerno F, Gerbes A, Gin\u00e8s P, Wong F, Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut. 2007;56(9):1310-8.","journal-title":"Gut"},{"issue":"4","key":"key20250331124123_B15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1590\/S0104-42302001000400039","article-title":"Utiliza\u00e7\u00e3o de recursos e custos em osteoporose","volume":"47","author":"Kowalski","year":"2001","unstructured":"15. Kowalski SC, Sjenzfeld VL, Ferraz MB. Utiliza\u00e7\u00e3o de recursos e custos em osteoporose. RevAssoc Med Bras. 2001;47(4):352-7.","journal-title":"RevAssoc Med Bras"},{"issue":"22","key":"key20250331124123_B16","first-page":"145","article-title":"Os m\u00e9todos de custeio: vantagens, desvantagens e sua aplicabilidade nos diversos tipos de organiza\u00e7\u00f5es apresentadas pela literatura","volume":"12","author":"Abbas","year":"2012","unstructured":"16. Abbas K, Gon\u00e7alves MN, Leoncine M. Os m\u00e9todos de custeio: vantagens, desvantagens e sua aplicabilidade nos diversos tipos de organiza\u00e7\u00f5es apresentadas pela literatura. ConTexto. 2012;12(22):145-59.","journal-title":"ConTexto"},{"key":"key20250331124123_B17","author":"The World Bank Group","year":"2021","unstructured":"17. The World Bank Group. The World Bank. PPP conversion factor, GDP (LCU per international $). USA: The World Bank Group; 2021 [cited 2021 Feb 7]. Available from: https:\/\/data.worldbank.org\/indicator\/PA.NUS.PPP","journal-title":"PPP conversion factor, GDP (LCU per international $)"},{"issue":"5","key":"key20250331124123_B18","doi-asserted-by":"crossref","first-page":"774","DOI":"10.2215\/CJN.12451018","article-title":"Hepatorenal Syndrome","volume":"14","author":"Francoz","year":"2019","unstructured":"18. Francoz C, Durand F, Kahn JA, Genyk YS, Nadim MK. Hepatorenal Syndrome. Clin J Am Soc Nephrol. 2019;14(5):774-81.","journal-title":"Clin J Am Soc Nephrol"},{"key":"key20250331124123_B19","first-page":"1","author":"Brasil","year":"2002","unstructured":"19. Brasil. Minist\u00e9rio da Sa\u00fade. Dados Gerais sobre o SUS. O Sistema P\u00fablico de Sa\u00fade Brasileiro. Bras\u00edlia (DF): Minist\u00e9rio da Sa\u00fade; 2002. p. 1-44.","journal-title":"Dados Gerais sobre o SUS. O Sistema P\u00fablico de Sa\u00fade Brasileiro"},{"issue":"1","key":"key20250331124123_B20","doi-asserted-by":"crossref","DOI":"10.1186\/s13613-017-0249-6","article-title":"Prognosis of cirrhotic patients admitted to intensive care unit: a meta-analysis","volume":"7","author":"Weil","year":"2017","unstructured":"20. Weil D, Levesque E, McPhail M, Cavallazzi R, Theocharidou E, Cholongitas E, Galbois A, Pan HC, Karvellas CJ, Sauneuf B, Robert R, Fichet J, Piton G, Thevenot T, Capellier G, Di Martino V; METAREACIR Group. Prognosis of cirrhotic patients admitted to intensive care unit: a meta-analysis. Ann Intensive Care. 2017;7(1):33.","journal-title":"Ann Intensive Care"},{"issue":"2","key":"key20250331124123_B21","first-page":"8","article-title":"Costs of Intermediate Care and Intensive Care","volume":"7","author":"Capuzzo","year":"2007","unstructured":"21. Capuzzo M. Costs of Intermediate Care and Intensive Care. ICU Manag Pract. 2007;7(2):8-9.","journal-title":"ICU Manag Pract"},{"issue":"3","key":"key20250331124123_B22","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jhep.2013.11.012","article-title":"Outcome of patients with cirrhosis requiring mechanical ventilation in ICU","volume":"60","author":"Levesque","year":"2014","unstructured":"22. Levesque E, Saliba F, Icha\u00ef P, Samuel D. Outcome of patients with cirrhosis requiring mechanical ventilation in ICU. J Hepatol. 2014;60(3):570-8.","journal-title":"J Hepatol"},{"issue":"6","key":"key20250331124123_B23","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.jhep.2011.03.012","article-title":"Diagnosis, treatment and survival of patients with hepatorenal syndrome: a survey on daily medical practice","volume":"55","author":"Salerno","year":"2011","unstructured":"23. Salerno F, Cazzaniga M, Merli M, Spinzi G, Saibeni S, Salmi A, Fagiuoli S, Spadaccini A, Trotta E, Laffi G, Koch M, Riggio O, Boccia S, Felder M, Balzani S, Bruno S, Angeli P; Italian Association of the Hospital Gastroenterologists (AIGO) investigators. Diagnosis, treatment and survival of patients with hepatorenal syndrome: a survey on daily medical practice. J Hepatol. 2011;55(6):1241-8.","journal-title":"J Hepatol"},{"issue":"10","key":"key20250331124123_B24","article-title":"APACHE II: a severity of disease classification system","volume":"13","author":"Knaus","year":"1985","unstructured":"24. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. CriticalCareMedice. 1985;13(10).","journal-title":"CriticalCareMedice"},{"key":"key20250331124123_B25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1590\/S1413-81232005000500029","article-title":"Farmacoeconomia: perspectiva emergente no processo de tomada de decis\u00e3o","volume":"10","author":"Secoli","year":"2005","unstructured":"25. Secoli SR, Padilha KG, Litvoc J, Maeda ST. Farmacoeconomia: perspectiva emergente no processo de tomada de decis\u00e3o. Cien Saude Colet. 2005;10 suppl:287-96.","journal-title":"Cien Saude Colet"}],"container-title":["einstein (S\u00e3o Paulo)"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T13:04:08Z","timestamp":1743426248000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.einstein.br\/article\/hepatorenal-syndrome-direct-treatment-costs-and-characteristics-of-patients-admitted-to-intensive-care\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":25,"alternative-id":["10.31744\/einstein_journal\/2025GS0390"],"URL":"https:\/\/doi.org\/10.31744\/einstein_journal\/2025gs0390","relation":{},"ISSN":["1679-4508","2317-6385"],"issn-type":[{"type":"print","value":"1679-4508"},{"type":"electronic","value":"2317-6385"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"eGS0390"}}